MNYIX Performance — BNY Mellon New York Intermediate Tax-Exempt Bond Fund, Investor Shares
Data updated: 2025-07-29
MNYIX returned +3.12% over one year to May 2025. Annualised returns are +2.01% over 3 years and +0.73% over 5 years. The fund beat its Intermediate Municipal Bond category average: $100 invested three years ago grew to $106, against $105 for the category, and to $103 over one year, against $102. Volatility over the past three years was 6.08% a year. In the 12 months to May 2025 the fund lost a net $6.9M, and assets reached $86.71M.
MNYIX Growth of $100
What $100 invested in BNY Mellon New York Intermediate Tax-Exempt Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Municipal Bond category average over the same months.
| Period | MNYIX | Category average |
|---|---|---|
| 1 year (Jun 2024 – May 2025) | $103 | $102 |
| 3 years (Jun 2022 – May 2025) | $106 | $105 |
| 5 years (Jun 2020 – May 2025) | $104 | $103 |
| Since data start (Sep 2019 – May 2025) | $102 | $103 |
MNYIX Trailing Returns
Total returns to May 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +3.12% |
| 3 years (annualised) | +2.01% |
| 5 years (annualised) | +0.73% |
MNYIX Annual Returns
Calendar-year total returns of BNY Mellon New York Intermediate Tax-Exempt Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–May) | −0.03% |
| 2024 | +1.11% |
| 2023 | +5.57% |
| 2022 | −8.20% |
| 2021 | +1.47% |
| 2020 | +3.26% |
| 2019 (Sep–Dec) | −0.46% |
MNYIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.5% | +0.9% | −1.3% | −0.4% | +0.3% | — | — | — | — | — | — | — |
| 2024 | −0.2% | 0.0% | −0.1% | −1.1% | −0.6% | +1.3% | +0.9% | +1.1% | +0.8% | −1.4% | +1.4% | −1.1% |
| 2023 | +2.7% | −2.0% | +1.9% | −0.1% | −0.9% | +0.8% | +0.2% | −0.9% | −2.6% | −0.9% | +5.4% | +2.1% |
| 2022 | −2.6% | −0.6% | −3.1% | −2.6% | +1.0% | −1.3% | +2.3% | −1.8% | −3.2% | −0.5% | +3.9% | +0.3% |
| 2021 | +0.8% | −1.4% | +0.5% | +0.9% | +0.5% | +0.2% | +0.7% | −0.3% | −0.8% | −0.3% | +0.7% | 0.0% |
| 2020 | +1.8% | +1.3% | −4.8% | −1.7% | +2.5% | +1.3% | +1.3% | −0.2% | −0.3% | −0.2% | +1.5% | +0.8% |
| 2019 | — | — | — | — | — | — | — | — | −0.9% | 0.0% | +0.1% | +0.3% |
MNYIX Risk
Risk measures from monthly returns over Jun 2022 – May 2025.
- 3-year volatility (annualised): 6.08%
- 3-year Sharpe ratio: -0.41 (vs 4.5% risk-free rate)
- Best month: +5.38% (Nov 2023)
- Worst month: −3.17% (Sep 2022)
MNYIX Fund Flows
Monthly money in and out of BNY Mellon New York Intermediate Tax-Exempt Bond Fund, from SEC Form N-PORT.
- 12-month net flow: −$6.9M
- 12-month gross sales (incl. reinvestments): $19.3M
- Sales ÷ redemptions: 0.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2025 | $1.7M | $1.2M | $501K |
| Apr 2025 | $1.6M | $2.5M | −$977K |
| Mar 2025 | $480K | $2.1M | −$1.7M |
| Feb 2025 | $4.1M | $1.1M | $2.9M |
| Jan 2025 | $1.8M | $1.8M | $12K |
| Dec 2024 | $1.3M | $1.9M | −$572K |
| Nov 2024 | $2.0M | $2.3M | −$289K |
| Oct 2024 | $1.1M | $2.8M | −$1.7M |
| Sep 2024 | $812K | $1.8M | −$965K |
| Aug 2024 | $2.6M | $3.5M | −$864K |
| Jul 2024 | $781K | $2.3M | −$1.5M |
| Jun 2024 | $989K | $2.8M | −$1.8M |
MNYIX Assets Under Management
Net assets of BNY Mellon New York Intermediate Tax-Exempt Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-05-31 | $86.71M |
| 2025-02-28 | $90.67M |
| 2024-11-30 | $88.34M |
| 2024-08-31 | $91.07M |
| 2024-05-31 | $92.69M |
| 2024-02-29 | $95.67M |
| 2023-11-30 | $97.29M |
| 2023-08-31 | $106.88M |
| 2023-05-31 | $105.08M |
| 2023-02-28 | $104.10M |
| 2022-11-30 | $115.95M |
| 2022-08-31 | $122.94M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.